KStephanopoulos
TL3 Regular · Valencia, ES
Reads the primary literature and posts summaries with page numbers. Prefers being corrected to being agreed with.
Joined 15 August 2024 · last posted 10h
149 posts, newest first. Showing up to 150.
-
What a reversed-phase purity number actually is Replied, post #101 · Analytics › HPLC & UHPLC · 27 Jul 2026 · 20 likes Method validation is the demonstration that a method can separate the compound from its degradation products and impurities reliably. A method that cannot resolve an…
-
Here for the analytics and not much else Replied, post #97 · Lounge › Introductions · 26 Jul 2026 · 0 likes Say hello. No question required. Introduce yourself if you want to give context for why you are here, or just introduce yourself because you like meeting people.
-
What a certificate commits its issuer to Replied, post #107 · Analytics › COA interpretation · 26 Jul 2026 · 1 like Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #147 · Sourcing › Logistics · 26 Jul 2026 · 0 likes Picking up post #144: that is the part I would want checked first. Reshipment after seizure: if a parcel is seized, some suppliers will reship; others will not. That is…
-
Restarting after a long gap: what the labelling implies Replied, post #43 · Practice › Dosing & titration · 25 Jul 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Athletes in weight-category sports: a different risk calculus Replied, post #37 · Clinical › Special populations · 23 Jul 2026 · 11 likes This follows post #34 rather than contradicting it. Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent…
-
Micro-titration: a disputed topic, argued properly Replied, post #109 · Practice › Dosing & titration · 23 Jul 2026 · 24 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #41 · Practice › Dosing & titration · 22 Jul 2026 · 1 like post #40 is right about the mechanism and I think understates the practical bit. Micro-titration: the concept of increments smaller than the labelled steps. It has no…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #56 · Sourcing › Regulatory · 22 Jul 2026 · 24 likes Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds with no human data are being used on theoretical grounds. The…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #53 · Access › Insurance & coverage · 21 Jul 2026 · 0 likes Worth separating two things that post #49 runs together. Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary…
-
The anatomy of a question that gets answered within an hour Replied, post #120 · Start Here › How to Ask · 21 Jul 2026 · 21 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Follow-up: Signs of dehydration worth acting on Replied, post #31 · Safety › Adverse events · 20 Jul 2026 · 27 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #125 · Evidence › Journal club · 19 Jul 2026 · 9 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #44 · Analytics › HPLC & UHPLC · 17 Jul 2026 · 16 likes This follows post #41 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Insurance and replacement policies, compared Replied, post #95 · Sourcing › Logistics · 17 Jul 2026 · 6 likes Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a handling problem in transit. The contents may or may not be…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #97 · Analytics › Home & field testing · 16 Jul 2026 · 3 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
-
Second pass at: Absence of evidence and evidence of absence Replied, post #46 · Research Methods › Statistics · 16 Jul 2026 · 7 likes I read post #44 twice before replying, because I had assumed the opposite. Absence of evidence and evidence of absence: if a study is small and finds no effect, that is…
-
What steady state means for the decision to escalate Replied, post #29 · Practice › Dosing & titration · 14 Jul 2026 · 0 likes Picking up post #26: that is the part I would want checked first. Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #71 · Analytics › Impurities & related substances · 12 Jul 2026 · 0 likes post #70 answers the question as asked. The question underneath it is different. Incomplete deprotection: mass higher by the protecting group mass. Usually markedly…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #42 · Evidence › Trials · 10 Jul 2026 · 18 likes Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple fact that people who agree to a multi-year…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #88 · Analytics › Home & field testing · 10 Jul 2026 · 11 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #48 · Analytics › Impurities & related substances · 4 Jul 2026 · 17 likes Picking up post #45: that is the part I would want checked first. Residual solvents: traces of solvents used in purification. These are usually tested by gas…
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #40 · Practice › Side effects · 4 Jul 2026 · 12 likes Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have changed (sleep, training volume, diet adequacy, hydration) before…
-
Journal club: what we got wrong in an earlier session Replied, post #49 · Evidence › Journal club · 3 Jul 2026 · 13 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #11 · Evidence › Journal club · 1 Jul 2026 · 0 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #87 · Data & Tools › Datasets · 28 Jun 2026 · 22 likes Using data in discussions: datasets are useful as reference points when someone claims something unusual. "I have not seen that reported in the data" is different from…
-
The anatomy of a question that gets answered within an hour Replied, post #91 · Start Here › How to Ask · 26 Jun 2026 · 0 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #7 · Compounds › Retatrutide · 20 Jun 2026 · 0 likes Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is where that question gets answered. Using phase 2 results to make…
-
Electrolyte supplements: which ones do anything Replied, post #34 · Nutrition & Training › Hydration & electrolytes · 19 Jun 2026 · 0 likes post #33 is right about the mechanism and I think understates the practical bit. Constipation and hydration: dehydration makes constipation worse. Increasing fluid…
-
Pooling trials with different estimands Replied, post #27 · Evidence › Meta-analyses · 15 Jun 2026 · 28 likes Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #20 · Access › Insurance & coverage · 14 Jun 2026 · 8 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Why this subcategory is stricter about sourcing than most Replied, post #39 · Compounds › Secretagogues & GH axis · 6 Jun 2026 · 0 likes CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin covalently and persists for days. The version without it does not persist.…
-
Alcohol: what is documented and what is folklore Replied, post #42 · Practice › Interactions · 5 Jun 2026 · 8 likes Worth separating two things that post #38 runs together. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #21 · Practice › Reconstitution · 31 May 2026 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Injection volume, overload, and peak distortion Replied, post #27 · Analytics › HPLC & UHPLC · 30 May 2026 · 0 likes Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #88 · Compounds › Tirzepatide · 25 May 2026 · 24 likes post #87 is right about the mechanism and I think understates the practical bit. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a…
-
Request: a per-category review queue Replied, post #2 · Meta › Feature requests · 23 May 2026 · 21 likes Tradeoffs: every feature has a cost in maintenance and complexity. Acknowledging tradeoffs shows you have thought through the implications.
-
Reading a home test result without over-claiming Replied, post #49 · Analytics › Home & field testing · 20 May 2026 · 32 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #16 · Evidence › Journal club · 8 May 2026 · 11 likes post #15 is right about the mechanism and I think understates the practical bit. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #93 · Clinical › Bloodwork · 7 May 2026 · 0 likes Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
-
The "under review" status pill and when a moderator applies it Replied, post #113 · Evidence › Preprints · 4 May 2026 · 0 likes Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…
-
Request: show the solution author in the topic list — what changed since Replied, post #37 · Meta › Feature requests · 2 May 2026 · 24 likes Alternatives: if you have thought of a way the current site might already serve your need, mention it. It helps assess whether the feature is truly missing or just not…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #50 · Sourcing › Logistics · 23 Apr 2026 · 7 likes This follows post #47 rather than contradicting it. At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days…
-
AOD-9604 and the fragment hypothesis, revisited — does this still hold? Replied, post #7 · Compounds › Other compounds · 20 Apr 2026 · 2 likes Worth separating two things that post #3 runs together. This subcategory exists because some people will research compounds outside the main groups discussed here. The…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #71 · Evidence › Trials · 15 Apr 2026 · 13 likes Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a stand-in. HbA1c is a surrogate for long-term glucose control and the…
-
Sample handling between despatch and injection Replied, post #41 · Analytics › Method validation · 15 Apr 2026 · 6 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Requesting a translation of an existing page — the long version Replied, post #4 · Documentation › Wiki requests · 14 Apr 2026 · 16 likes Request a new maintained page: if a question recurs, has a good marked solution, and contains a worked example, it is a candidate for promotion to a maintained…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #31 · Outcomes › Progress reports · 13 Apr 2026 · 4 likes Medication changes: escalating dose, or adding or removing other medications, can affect the rate of weight loss. Documenting medication changes alongside weight makes…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #23 · Practice › Administration · 2 Apr 2026 · 0 likes Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is ordinary. Whether you lost a "meaningful" dose depends on concentration and your…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #10 · Practice › Administration · 1 Apr 2026 · 3 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #13 · Evidence › Journal club · 23 Mar 2026 · 0 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
[2026 update] What a purity-only report leaves out Replied, post #61 · Sourcing › Independent verification · 21 Mar 2026 · 3 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #67 · Practice › Reconstitution · 18 Mar 2026 · 0 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #79 · Practice › Storage & stability · 10 Mar 2026 · 8 likes Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags. Faint opalescence or minor colour shift may be normal but…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #47 · Sourcing › Logistics · 1 Mar 2026 · 10 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Measurement error in a self-reported exposure Replied, post #3 · Evidence › Study critique · 21 Feb 2026 · 0 likes Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #65 · Evidence › Study critique · 18 Feb 2026 · 2 likes Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes from -1 to +5. But assuming the worst-case scenario is not…
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #32 · Analytics › Impurities & related substances · 13 Feb 2026 · 2 likes Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #36 · Outcomes › Progress reports · 11 Feb 2026 · 0 likes Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the medication stopped working. It is not evidence that it is…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #99 · Compounds › Semaglutide · 21 Jan 2026 · 25 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #64 · Access › International · 20 Jan 2026 · 2 likes Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #34 · Practice › Interactions · 12 Jan 2026 · 15 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #6 · Clinical › Special populations · 3 Jan 2026 · 12 likes Adolescents: a distinct evidence base exists. The compounds are not approved for routine adolescent obesity but are being studied. Adolescent physiology and psychology…
-
Preprint servers and what screening they do Replied, post #13 · Evidence › Preprints · 1 Jan 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #63 · Practice › Side effects · 28 Dec 2025 · 32 likes Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some people. Site rotation, avoiding reinjection into the same area…
-
Tracking a preprint to publication: a worked example Replied, post #64 · Evidence › Preprints · 6 Dec 2025 · 0 likes Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…
-
Tracking a preprint to publication: a worked example Replied, post #33 · Evidence › Preprints · 3 Dec 2025 · 0 likes post #32 answers the question as asked. The question underneath it is different. How to cite a preprint: author last name, first initial, et al. Title. Server name…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #37 · Sourcing › Regulatory · 2 Dec 2025 · 5 likes post #36 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Angle of injection and whether 90 degrees is always right Replied, post #57 · Practice › Administration · 28 Nov 2025 · 8 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #79 · Analytics › COA interpretation · 28 Nov 2025 · 6 likes Picking up post #76: that is the part I would want checked first. Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent water is…
-
What a purity-only report leaves out Replied, post #78 · Sourcing › Independent verification · 8 Nov 2025 · 0 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
EMA product information as a primary source Replied, post #39 · Regional › European Union · 6 Nov 2025 · 0 likes Cross-border purchase rules: buying a prescription in one EU country and bringing it home is complex. The substance is legal but crossing borders with it requires…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #93 · Safety › Adverse events · 4 Nov 2025 · 14 likes Coming back to post #91, because the follow-up matters more than the original answer. Severe gastrointestinal events: persistent vomiting, abdominal pain out of…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #78 · Safety › Adverse events · 1 Nov 2025 · 10 likes post #77 answers the question as asked. The question underneath it is different. How to document: date, exact symptom or event, severity, duration, outcome, any medical…
-
Reconciling a supplier certificate with an independent result Replied, post #19 · Sourcing › Vendor reports · 31 Oct 2025 · 8 likes This follows post #16 rather than contradicting it. Blind submission is worth the effort: have someone else relabel the sample so neither you nor the laboratory knows…
-
Research-use-only labelling: what it means and what it does not Replied, post #52 · Sourcing › Regulatory · 29 Oct 2025 · 0 likes Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
-
A 40-week log with the measurement method stated Replied, post #86 · Outcomes › Progress reports · 28 Oct 2025 · 0 likes Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool; use the same one each time. Consistency matters more than…
-
A 40-week log with the measurement method stated Replied, post #65 · Outcomes › Progress reports · 24 Oct 2025 · 14 likes Measurement noise: day-to-day body mass varies by more than a kilogram on hydration, glycogen, and gut contents alone. A weekly reading is a single noisy sample of a…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #14 · Clinical › Special populations · 16 Oct 2025 · 6 likes Worth separating two things that post #10 runs together. Hepatic impairment: less is known about dosing in significant liver disease than in kidney disease. Extreme…
-
What I would record differently if I started again — the long version Replied, post #13 · Outcomes › Progress reports · 15 Oct 2025 · 5 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
-
Second pass at: The mass-error checker and its intended scope Replied, post #31 · Data & Tools › Calculators · 4 Oct 2025 · 4 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
History of disordered eating and why it changes the conversation Replied, post #15 · Clinical › Special populations · 30 Sep 2025 · 0 likes Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait before attempting pregnancy) are not formally…
-
Freeze-thaw and why one cycle is not the same as five Replied, post #5 · Practice › Storage & stability · 25 Sep 2025 · 9 likes Picking up post #2: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
The headache that turns out to be dehydration Replied, post #2 · Nutrition & Training › Hydration & electrolytes · 18 Sep 2025 · 13 likes the opening post is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive…
-
Managing an unplanned gap in supply — what changed since Replied, post #64 · Access › Shortages · 17 Sep 2025 · 12 likes Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #65 · Practice › Administration · 17 Sep 2025 · 13 likes On post #61 — agreed on the reasoning, with one qualification. A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through…
-
Thyroid function tests during substantial weight change Replied, post #52 · Clinical › Bloodwork · 5 Sep 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Asking about a compound your prescriber has not heard of Replied, post #140 · Clinical › Prescriber conversations · 28 Aug 2025 · 21 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #90 · Evidence › Journal club · 22 Aug 2025 · 17 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A request that was declined, and the reasoning — a second dataset Replied, post #40 · Documentation › Wiki requests · 9 Aug 2025 · 2 likes I read post #38 twice before replying, because I had assumed the opposite. Flag a page that has drifted: if you notice a maintained page has information that is…
-
Are there stupid questions here? A staff answer, at length Replied, post #39 · Start Here › Welcome · 4 Aug 2025 · 0 likes This follows post #36 rather than contradicting it. Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #99 · Practice › Reconstitution · 4 Aug 2025 · 11 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Why the timeline is on the right and not the left Replied, post #49 · Meta › Site feedback · 3 Aug 2025 · 0 likes post #48 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Travel coolers and how long they really hold Replied, post #29 · Devices › Cold chain · 2 Aug 2025 · 2 likes post #28 is right about the mechanism and I think understates the practical bit. Reconstituted solutions: once reconstituted, solutions are less stable than lyophilised…
-
Canadian access and provincial variation — one year on Replied, post #42 · Regional › North America · 28 Jul 2025 · 0 likes This follows post #39 rather than contradicting it. Provincial formularies in Canada are published and are the correct source for coverage information. Coverage for…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #35 · Practice › Dosing & titration · 27 Jul 2025 · 2 likes post #34 answers the question as asked. The question underneath it is different. Stepping down deliberately: the withdrawal trials show that stopping is followed by…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #3 · Start Here › How to Ask · 24 Jul 2025 · 22 likes Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which one holds. Do not open with "I think you are wrong". Lead with…
-
Interpreting a composition change that is within the error bars Replied, post #20 · Outcomes › Body composition · 23 Jul 2025 · 2 likes post #19 is right about the mechanism and I think understates the practical bit. Lean mass loss during rapid weight reduction: depends on protein intake, resistance…
-
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #13 · Compounds › Cagrilintide & amylin analogues · 19 Jul 2025 · 24 likes I read post #11 twice before replying, because I had assumed the opposite. Is synergy the right word for the combination data? A phase 2 trial cannot establish whether…
-
The storage lookup and where its data comes from Replied, post #6 · Data & Tools › Calculators · 14 Jul 2025 · 11 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
What this community means by "a source", in practical terms Replied, post #31 · Start Here › Welcome · 11 Jul 2025 · 15 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #68 · Nutrition & Training › Protein & intake · 12 Jun 2025 · 21 likes Picking up post #65: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Why oral semaglutide needs an absorption enhancer at all — what changed since Replied, post #3 · Compounds › Oral incretins · 7 Jun 2025 · 20 likes post #2 answers the question as asked. The question underneath it is different. Oral bioavailability is variable between people. Some people absorb well; others absorb…
-
Half-life, steady state, and accumulation worked through Replied, post #70 · Pharmacology › Pharmacokinetics · 5 Jun 2025 · 0 likes post #69 answers the question as asked. The question underneath it is different. Accumulation at steady state: with a week-long half-life, steady-state concentration is…
-
Coming back to: Cross-border purchase rules within the EU Replied, post #7 · Regional › European Union · 31 May 2025 · 1 like Coming back to post #5, because the follow-up matters more than the original answer. Private prescription with self-payment is legal across the EU and is the common…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #12 · Clinical › Special populations · 22 May 2025 · 2 likes Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe renal impairment. Consulting with a clinician familiar…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #33 · Outcomes › Body composition · 12 May 2025 · 6 likes Bioelectric impedance analysis: less precise than DXA and strongly affected by hydration state. Not reliable for detecting month-to-month changes. Useful for trend over…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #77 · Sourcing › Independent verification · 11 May 2025 · 3 likes post #76 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Reading a trial's population section before its results — does this still hold? Replied, post #89 · Evidence › Trials · 10 May 2025 · 11 likes Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug. Per-protocol includes only those who completed it as…
-
Deamidation and the close-eluting pair it produces Replied, post #36 · Analytics › Impurities & related substances · 2 May 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Follow-up: Requesting a page: what makes a good request Replied, post #26 · Documentation › Wiki requests · 25 Apr 2025 · 0 likes Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues, contrast problems, small text) report it. Accessibility matters.
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #26 · Clinical › Comorbidities · 25 Apr 2025 · 13 likes This follows post #23 rather than contradicting it. PCOS and metabolic overlap: polycystic ovary syndrome has metabolic overlap with obesity and insulin resistance.…
-
Second pass at: Reading a combination trial: attributing effect to components Replied, post #9 · Compounds › Cagrilintide & amylin analogues · 25 Apr 2025 · 4 likes Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are synergistic or additive. Synergy is a mechanistic claim that…
-
Review cadence: how often is a page actually re-checked? Replied, post #24 · Documentation › Doc review · 18 Apr 2025 · 18 likes Promoted topic withdrawal: if a promoted topic becomes outdated or inaccurate and the maintainer does not update, requesting withdrawal is appropriate.
-
Documenting an adverse event properly — the long version Started this topic · Safety › Adverse events · 17 Apr 2025 · 10 likes Posting this under the heading it deserves: Documenting an adverse event properly — the long version Everything below is what sits behind that. General question, not a…
-
Retatrutide dose escalation in the published trials Replied, post #134 · Compounds › Retatrutide · 15 Apr 2025 · 10 likes Coming back to post #132, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Scheduled maintenance and what will be unavailable Replied, post #89 · Meta › Announcements · 28 Mar 2025 · 14 likes When announcements are made: major policy changes, technical changes affecting site function, planned downtime, and changes to guidelines all get announced here.
-
Follow-up: Requesting a page: what makes a good request Replied, post #13 · Documentation › Wiki requests · 23 Mar 2025 · 6 likes Suggesting content for a page: if you know a maintained page is missing something important, post a suggestion with specific content you think should be added.
-
What a 2 ppm match establishes, and what it does not Replied, post #6 · Analytics › Mass spectrometry · 18 Mar 2025 · 10 likes On post #2 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #12 · Sourcing › Vendor reports · 15 Mar 2025 · 7 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #2 · Sourcing › Independent verification · 9 Mar 2025 · 4 likes This follows the opening post rather than contradicting it. Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #57 · Sourcing › Red flags · 25 Feb 2025 · 18 likes Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming…
-
Fibre intake when total intake falls, and the constipation link Replied, post #32 · Nutrition & Training › Protein & intake · 23 Feb 2025 · 4 likes On post #28 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #113 · Compounds › Semaglutide · 23 Feb 2025 · 0 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #22 · Compounds › Tirzepatide · 16 Feb 2025 · 10 likes This follows post #19 rather than contradicting it. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The…
-
Follow-up: Attributing a new peak: degradation product or excipient? Started this topic · Analytics › Impurities & related substances · 13 Feb 2025 · 0 likes Attributing a new peak: degradation product or excipient? I have a specific reason for asking rather than idle curiosity, and the context is below. Posting the method…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #98 · Evidence › Meta-analyses · 12 Feb 2025 · 0 likes Why forest plots are more informative than pooled numbers: they show the variation across studies, which tells you whether the effect is consistent or heterogeneous. A…
-
How compounding permissions changed when supply normalised Replied, post #16 · Sourcing › Regulatory · 6 Feb 2025 · 30 likes Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #10 · Compounds › Repair & healing peptides · 30 Jan 2025 · 23 likes For anyone arriving from search engines: this subcategory discusses published preclinical work and the absence of published clinical work. It does not endorse or…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #50 · Compounds › Oral incretins · 14 Jan 2025 · 0 likes Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a transient pH effect in the stomach. Anything that…
-
Second pass at: Historical amylin analogues and what happened to them Replied, post #6 · Compounds › Cagrilintide & amylin analogues · 7 Jan 2025 · 0 likes For anyone arriving from searches on "amylin agonist": this subcategory discusses published clinical evidence and what it does and does not establish. It does not…
-
What changed in 2026, by region Replied, post #49 · Access › International · 31 Dec 2024 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #135 · Clinical › Prescriber conversations · 30 Dec 2024 · 8 likes Understanding stopping rules: what would prompt stopping the compound? Adverse effect, lack of benefit after a defined time, or other reasons? Knowing in advance is…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #99 · Compounds › Semaglutide · 25 Dec 2024 · 26 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
-
A promotion I argued against, and why I lost Replied, post #21 · Documentation › Doc review · 5 Dec 2024 · 0 likes This follows post #18 rather than contradicting it. Evidence synthesis requests: if you think a page should summarise the state of evidence on a question, and you think…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #4 · Practice › Reconstitution · 18 Nov 2024 · 0 likes This follows post #2 rather than contradicting it. Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #65 · Devices › Syringes & needles · 14 Nov 2024 · 0 likes Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to 0.02 mL for an insulin syringe with a fixed needle. Accounting for it…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #22 · Evidence › Journal club · 2 Nov 2024 · 0 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Requesting a page: what makes a good request — what changed since Replied, post #2 · Documentation › Wiki requests · 8 Oct 2024 · 0 likes Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues, contrast problems, small text) report it. Accessibility matters.
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #63 · Evidence › Journal club · 4 Oct 2024 · 8 likes This follows post #60 rather than contradicting it. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for…
-
Individual participant data versus aggregate data Replied, post #2 · Evidence › Meta-analyses · 14 Sep 2024 · 16 likes Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by quality, to see whether the pooled estimate changes. Robust results…
-
Cold packs, phase-change material, and what survives ten days — does this still hold? Replied, post #2 · Sourcing › Logistics · 5 Sep 2024 · 0 likes Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.
-
Signs of dehydration worth acting on Replied, post #7 · Safety › Adverse events · 20 Aug 2024 · 6 likes On post #3 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #33 · Analytics › Mass spectrometry · 16 Aug 2024 · 0 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
-
Identical chromatograms across two different lots Replied, post #10 · Sourcing › Red flags · 30 Jul 2024 · 3 likes Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming…
-
Journal club: FLOW and the renal composite, component by component Replied, post #75 · Evidence › Journal club · 16 Jul 2024 · 33 likes Coming back to post #73, because the follow-up matters more than the original answer. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be…
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #35 · Practice › Interactions · 12 Jul 2024 · 13 likes Worth separating two things that post #31 runs together. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by…
-
Cold packs, phase-change material, and what survives ten days Replied, post #55 · Sourcing › Logistics · 29 Jun 2024 · 24 likes Picking up post #52: that is the part I would want checked first. Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they…
-
The mass-error checker and its intended scope Replied, post #31 · Data & Tools › Calculators · 5 Jun 2024 · 0 likes Precision and significant figures: the calculators do not round to match your input precision. If you input values to one decimal place, the output might have more. Use…